Etebenecid

CAS No. 1213-06-5

Etebenecid( Urelim )

Catalog No. M26681 CAS No. 1213-06-5

Etebenecid is uricosuric agents, which lower uric acid levels in the body by increasing the elimination of uric acid by the kidneys.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 46 Get Quote
100MG 72 Get Quote
500MG 177 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Etebenecid
  • Note
    Research use only, not for human use.
  • Brief Description
    Etebenecid is uricosuric agents, which lower uric acid levels in the body by increasing the elimination of uric acid by the kidneys.
  • Description
    Etebenecid is uricosuric agents, which lower uric acid levels in the body by increasing the elimination of uric acid by the kidneys. It also inhibits penicillin tubular secretion.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Urelim
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    prostaglandin F2α
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1213-06-5
  • Formula Weight
    257.3
  • Molecular Formula
    C11H15NO4S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 250 mg/mL (971.59 mM)
  • SMILES
    CCN(CC)S(=O)(=O)c1ccc(cc1)C(O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Vallera C, et al. Uterotonic Medications: Oxytocin, Methylergonovine, Carboprost, Misoprostol. Anesthesiol Clin. 2017 Jun;35(2):207-219.
molnova catalog
related products
  • L-allo-Isoleucine

    L-alloisoleucine is a branched chain amino acid and is a stereoisomer of L-isoleucine. It is a common constituent of human plasma (albeit at low levels). L-alloisoleucine is produced as a byproduct of isoleucine transamination. Plasma L-alloisoleucine which is derived from L-isoleucine in vivo can be used for the diagnosis of maple syrup urine disease (MSUD) a genetic disorder.

  • Licoflavonol

    Licoflavonol is a novel natural inhibitor of Salmonella T3SS, could be a promising candidate for novel type of anti-virulence drugs, it exhibits a strong inhibitory effect on the secretion of the SPI-1 effector proteins via regulating the transcription of the SicA/InvF genes, and the transportation of the effector protein SipC.

  • Dihydrosinapyl alcoh...

    Dihydrosinapyl alcohol is a natural product from Clerodendranthus spicatus.